News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Novartis AG (JOBS), Pfizer Inc. (JOBS) Cancer Drugs Halt Type 1 Diabetes in Mice
November 18, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO, Nov 17 (Reuters) - Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from developing type 1 diabetes and put 80 percent of diabetic mice in remission, an international team said on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Preclinical
Pfizer
Novartis
MORE ON THIS TOPIC
Rare diseases
BridgeBio Builds Case for Early 2027 Launch of Dystrophy Drug
March 12, 2026
·
2 min read
·
Tristan Manalac
Clinical research
MDA 2026: Biogen, Sarepta, Edgewise Address Muscle Disorders
March 12, 2026
·
3 min read
·
Tristan Manalac
Insights
From Two Trials to One, Sponsors Face a Higher Standard
March 12, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Duchenne muscular dystrophy
Dyne Plans Post-Prasad FDA Run as Duchenne Exon Skipper Sustains Benefit in Long Term Data
March 10, 2026
·
3 min read
·
Tristan Manalac
